Press release
Diabetic Eye Disease Market to Reach USD 13.84 Billion by 2034
Diabetic Eye Disease
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72009
Market Summary
The Diabetic Eye Disease Market is growing rapidly as diabetic retinopathy (DR) and diabetic macular edema (DME) emerge as leading causes of preventable blindness worldwide. With rising type 2 diabetes cases and longer disease duration, the global patient pool continues to increase.
Diagnosis is becoming more precise with OCT, OCT-A, fundus photography, AI-based screening, and digital retinal assessment platforms. Anti-VEGF therapies (ranibizumab, aflibercept, bevacizumab) dominate treatment, while corticosteroid implants (dexamethasone, fluocinolone) play a crucial role in refractory DME. Emerging therapies include longer-acting biologics, sustained-release drug delivery systems, and gene therapy pipelines aimed at reducing treatment burden.
North America leads due to strong screening infrastructure and therapy adoption, while Asia-Pacific is the fastest-growing region with rapidly rising diabetic populations and increasing awareness.
Key Takeaways
• 2024 Market Size: USD 7.89 Billion
• 2034 Forecast: USD 13.84 Billion
• CAGR: 5.8% (2025-2034)
• Anti-VEGF therapy remains the gold standard for DME & vision preservation
• AI-based diabetic retinopathy screening programs expanding globally
• Asia-Pacific shows fastest growth due to rising diabetes prevalence
Market Drivers
• Rapid increase in Type 2 diabetes and obesity worldwide
• Expansion of retinal screening programs & tele-ophthalmology
• Growing adoption of anti-VEGF injections and sustained-release implants
• Advancements in retinal imaging & digital diagnostic tools
• Increasing government initiatives for blindness prevention
Segmentation Snapshot
By Disease Type
• Diabetic Retinopathy (NPDR, PDR)
• Diabetic Macular Edema (DME)
• Diabetic Cataract
• Glaucoma Associated with Diabetes
By Treatment
• Anti-VEGF Therapies (Aflibercept, Ranibizumab, Bevacizumab)
• Corticosteroid Implants (Dexamethasone, Fluocinolone)
• Laser Therapy (Focal/Grid, Pan-retinal Photocoagulation)
• Vitrectomy
• Emerging Gene & Long-Acting Therapies
By Diagnostic Method
• Optical Coherence Tomography (OCT)
• OCT Angiography (OCTA)
• Fundus Photography
• Fluorescein Angiography
• AI-Based DR Screening Platforms
By End User
• Hospitals
• Ophthalmology Clinics
• Specialty Eye Centers
• Diagnostic Imaging Centers
• Tele-Ophthalmology Networks
By Region
• North America (Largest Market)
• Europe
• Asia-Pacific (Fastest Growing)
• Latin America
• Middle East & Africa
Explore Full Report here: https://exactitudeconsultancy.com/reports/72009/diabetic-eye-disease-market
Recent Developments
• Expansion of long-acting anti-VEGF therapies, reducing injection frequency.
• AI-driven DR screening approved in multiple regions for primary care use.
• Increased investments in gene therapy for retinal vascular diseases.
• Broadening adoption of sustained-release steroid implants for chronic DME.
Expert Quote - Irfan Tamboli, Business Development Executive
"Diabetic eye disease is one of the most preventable causes of blindness. With advanced imaging, AI screening, and next-generation retinal therapies, patient outcomes continue to improve globally."
Conclusion
The Diabetic Eye Disease Market will continue expanding through 2034 as global diabetes cases rise, screening programs grow, and innovative biologic and device-based ophthalmic therapies evolve. Companies investing in AI-driven diagnostics, long-acting treatments, and integrated diabetic care platforms will lead future market transformation.
This report is also available in the following languages : Japanese (糖尿病性眼疾患市場), Korean (당뇨병성 안구 질환 시장), Chinese (糖尿病眼病市场), French (Marché des maladies oculaires diabétiques), German (Markt für diabetische Augenerkrankungen), and Italian (Mercato delle malattie oculari diabetiche), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/72009
Related Reports
Retinal Vein Occlusion Market
https://exactitudeconsultancy.com/reports/72291/retinal-vein-occlusion-market
Wet Macular Degeneration Market
https://exactitudeconsultancy.com/reports/72292/wet-macular-degeneration-market
Vitreoretinal Surgery Devices Market
https://exactitudeconsultancy.com/reports/72307/vitreoretinal-surgery-devices-market
Unattended Fundus Camera Market
https://exactitudeconsultancy.com/reports/75277/unattended-fundus-camera-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Diabetic Eye Disease Market to Reach USD 13.84 Billion by 2034 here
News-ID: 4304515 • Views: …
More Releases from Exactitude Consultancy
Dementia with Lewy Bodies (DLB) Growing Patient Pool Spurs Demand for Diagnosis …
Snippet / Teaser:
As medical awareness improves and diagnostic capabilities expand, the global Dementia with Lewy Bodies (DLB) patient pool is growing - creating rising demand for diagnostics, therapies, and long-term care. The DLB market is emerging as a critical segment within dementia care, offering significant opportunities for healthcare providers, pharma, and care services worldwide.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72099
1. Keyword Definition - Dementia with Lewy Bodies (DLB)
Dementia…
Contrast-Induced Nephropathy (CIN) Market to Reach USD 1.92 Billion by 2034
Pune, India - December 2025 - The global Contrast-Induced Nephropathy (CIN) Market, valued at USD 1.14 billion in 2024, is projected to reach USD 1.92 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. With rising use of contrast-enhanced imaging procedures and growing incidence of chronic kidney disease (CKD), diabetes, and cardiovascular disorders, demand for CIN prevention and management solutions is rising steadily.
Download Full PDF Sample…
Alzheimer's Disease Market Set for Major Growth Demand 2034
With global demographic shifts toward older populations and breakthroughs in diagnostics and therapy, the Alzheimer's disease market is poised for significant growth. Rising prevalence, increasing early detection, and greater demand for care make Alzheimer's a key growth area for healthcare stakeholders worldwide.
Download Full PDF Sample Copy of Market Report
https://exactitudeconsultancy.com/request-sample/72097
1. Keyword Definition - Alzheimer's Disease (AD)
Alzheimer's Disease (AD) is a progressive neurodegenerative condition characterized by memory loss, cognitive decline, impaired…
Adrenal Insufficiency Market to Reach USD 4.03 Billion by 2034
Pune, India - December 2025 - The global Adrenal Insufficiency Market, valued at USD 2.38 billion in 2024, is projected to reach USD 4.03 billion by 2034, growing at a 5.4% CAGR (2025-2034), according to Exactitude Consultancy. Rising prevalence of autoimmune disorders, enhanced diagnostic awareness, and advancements in glucocorticoid replacement therapies are fueling consistent market growth.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/72005
Market Summary
The Adrenal Insufficiency Market is…
More Releases for Diabetic
Exploring The Diabetic Retinopathy Market In A Diabetic-Prevalent World: The Dri …
Use code ONLINE20 to get 20% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Diabetic Retinopathy Market Size Growth Forecast: What to Expect by 2025?
The diabetic retinopathy market has experienced robust expansion over the last few years, with projections indicating a rise from $8.61 billion in 2024 next year to $9.26 billion in 2025, reflecting a compound annual growth rate (CAGR) of…
Diabetic Socks Market Dynamics Shaped by Rising Diabetic Population - Persistenc …
The diabetic socks market is gaining significant traction worldwide, driven by the rising prevalence of diabetes and related complications such as diabetic neuropathy and foot ulcers. Designed specifically to cater to the needs of diabetic patients, these socks play a crucial role in foot protection by preventing blistering, reducing moisture accumulation, and providing cushioning to minimize the risk of ulcers. This article delves deeply into the diabetic socks market, exploring…
Diabetic Food Market
Future Market Insights (FMI) delivers key insights on the global diabetic food market in its latest report titled “Diabetic Food Market: Global Industry Analysis and Opportunity Assessment, 2014 – 2020”. The global diabetic food market is expected to amplify at a CAGR of 5.9% during the forecast period in terms of value due to various factors, regarding which FMI offers fundamental insights in detail in this report.
On the basis of…
Diabetic Food Market
Diabetes refers to a metabolic disease which leads to high blood sugar levels. The main cause behind diabetes is the insufficient insulin or no response in the body cells where the insulin is produced. Diabetic foods are dietary products rich in carbohydrates and sugar content. They help in controlling rising blood glucose. Diabetic food is low in calorie sweeteners and diet beverages. These products are consumed by diabetic patients and…
Demand for Diabetic Socks Due to Rising Prevalence of Diabetic Neuropathy Expect …
According to the latest market report published by Persistence Market Research titled ‘Diabetic Socks Market: Global Industry Analysis 2012-2016 and Forecast 2017-2025,’ the global diabetic socks market is expected to expand at a CAGR of approximately 4.8% during the forecast period 2017-2025.
To know key findings Request Sample Report @: https://www.persistencemarketresearch.com/samples/19282
Global Diabetic Socks Market: Factors Impacting the Market
The primary factors driving the growth of the global diabetic socks market are increasing…
Diabetic Food Market -
In recent times, diabetes has emerged as one of the most challenging health conditions across the world. According to the WHO, a total of 415 million cases of diabetes were reported globally in 2015. The count is rising at an alarming rate and is expected to reach 642 million in the next 25 years. Till now no medication has been found that can completely cure diabetes. It can only be…
